The growth and maturation of the Winship Cancer Institute (Winship) as a new CCSG-supported cancer center requires the development of a strong and highly effective administration. The past two years have witnessed a full administrative reorganization and new personnel recruitment to Winship's administrative team. These transitions were accomplished as a process fully integrated with the development of the Winship Strategic Plan 2010-2015. The current capabilities and responsibilities of the Winship administrative team include the following roles: * Planning and evaluation activities to promote interdisciplinary and translational research * Financial management of all Winship funds and accounts * Shared resource management including budgetary oversight, rate structuring, and reporting * Management of Winship's facilities, space, and equipment * Support and coordination of membership applications and review processes * Coordination of information technology and informatics needs * Communications, development, public affairs, and education programs * Personnel management and human resource services * Management and coordination of Winship pilot grant program * Executive support to all Winship committees within the cancer center's enhanced organizational structure To fulfill its vision, Winship must expand its research enterprise, and highly effective administrative support will be critical in achieving this. Winship has the appropriate administrative processes to manage the cancer center's growth and a highly skilled administrative team to implement its strategic plan.
Winship administration provides direct grant, research, space, and other administrative services to 146 cancer center members and five shared resource facilities. The administrative team will optimize CCSG funds to continue to facilitate cancer research and manage Winship's essential operations.
|Havel, L S; Kline, E R; Salgueiro, A M et al. (2015) Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene 34:1979-90|
|Forghani, Parvin; Khorramizadeh, Mohammad R; Waller, Edmund K (2014) Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer. Cancer Med 3:215-24|
|Smith, Alicia K; Conneely, Karen N; Pace, Thaddeus W W et al. (2014) Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun 38:227-36|
|Ha, Shin-Woo; Weitzmann, M Neale; Beck Jr, George R (2014) Bioactive silica nanoparticles promote osteoblast differentiation through stimulation of autophagy and direct association with LC3 and p62. ACS Nano 8:5898-910|
|Nooka, Ajay K; Johnson, Heather R; Kaufman, Jonathan L et al. (2014) Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:852-7|
|Capaldo, Christopher T; Farkas, Attila E; Hilgarth, Roland S et al. (2014) Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins. Mol Biol Cell 25:2710-9|
|Sullivan, Harold C; Oprea-Ilies, Gabriela; Adams, Amy L et al. (2014) Triple-negative breast carcinoma in African American and Caucasian women: clinicopathology, immunomarkers, and outcome. Appl Immunohistochem Mol Morphol 22:17-23|
|Brodie, Seth A; Li, Ge; El-Kommos, Adam et al. (2014) Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer. Cancer Prev Res (Phila) 7:351-61|
|Wang, Hongyan; Wang, Ya (2014) Heavier ions with a different linear energy transfer spectrum kill more cells due to similar interference with the Ku-dependent DNA repair pathway. Radiat Res 182:458-61|
|Jurchenko, Carol; Chang, Yuan; Narui, Yoshie et al. (2014) Integrin-generated forces lead to streptavidin-biotin unbinding in cellular adhesions. Biophys J 106:1436-46|
Showing the most recent 10 out of 49 publications